Article

Genetic Contributions to Alcohol Use Disorder Treatment Outcomes: A Genome-wide Pharmacogenomics Study

2021-02-08

Abstract excerpt

<h4>ABSTRACT</h4> Naltrexone can aid in reducing alcohol consumption, while acamprosate supports abstinence; however, not all patients with alcohol use disorder (AUD) benefit from these treatments. Here we present the first genome-wide association study of AUD treatment outcomes based on data from the COMBINE and PREDICT studies of acamprosate and naltrexone, and the Mayo Clinic CITA study of acamprosate. Primary...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e5f49176-ee3d-54eb-81ac-4a550fe0cace
DOI: 10.1101/2021.02.03.21251107

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Genetic Contributions to Alcohol Use Disorder Treatment Outcomes: A Genome-wide Pharmacogenomics StudyDOI 10.1101/2021.02.03.21251107Read

Genetic contributions to alcohol use disorder treatment outcomes: a genome-wide pharmacogenomics studySemantic proximity Read

Human genetics and epigenetics of alcohol use disorder.Semantic proximity Read

Advances in Medications and Tailoring Treatment for Alcohol Use DisorderSemantic proximity Read

Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate.Semantic proximity Read

Bridging Genomics and Pharmacoepidemiology to Expand Treatment Options for Alcohol Use DisorderSemantic proximity Read

Diverse types of genomic evidence converge on alcohol use disorder risk genes.Semantic proximity Read

OPRM1 rs1799971 Polymorphism Predicts Differential Response to Extended-Release Naltrexone in Alcohol Use Disorder: The Interplay of Genetics and Motivation.Semantic proximity Read

Genetic analysis of alcohol use disorder: GWAS of alcohol use disorders identification test (AUDIT) and polygenic risk scores in an east slavic population.Semantic proximity Read

COMBINE genetics study: the pharmacogenetics of alcoholism treatment response: genes and mechanisms.Semantic proximity Read

Pharmacogenetically driven treatments for alcoholism: are we there yet?Semantic proximity Read

Genome-wide association study of treatment resistant depression highlights shared biology with metabolic traitsSemantic proximity Read

Post-GWAS analysis of six substance use traits improves the identification and functional interpretation of genetic risk loci.Semantic proximity Read